These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7742578)

  • 1. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
    Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
    Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
    Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.
    Grotz WH; Mundinger FA; Gugel B; Exner VM; Kirste G; Schollmeyer PJ
    Transplantation; 1995 Apr; 59(7):982-6. PubMed ID: 7709459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L; Casez JP; Bekri S; Gigante M; Champenois I; Cassuto-Viguier E; Jaeger P
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in long-term Chinese heart transplant recipients: a cross-sectional study.
    Chou NK; Su IC; Kuo HL; Chen YH; Yang RS; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2141-4. PubMed ID: 16980025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid loss of vertebral mineral density after renal transplantation.
    Julian BA; Laskow DA; Dubovsky J; Dubovsky EV; Curtis JJ; Quarles LD
    N Engl J Med; 1991 Aug; 325(8):544-50. PubMed ID: 1857390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.
    Grotz WH; Mundinger FA; Rasenack J; Speidel L; Olschewski M; Exner VM; Schollmeyer PJ
    Nephrol Dial Transplant; 1995 Nov; 10(11):2096-100. PubMed ID: 8643174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone density loss during treatment of chronic GVHD.
    Stern JM; Chesnut CH; Bruemmer B; Sullivan KM; Lenssen PS; Aker SN; Sanders J
    Bone Marrow Transplant; 1996 Mar; 17(3):395-400. PubMed ID: 8704693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of time-interval after transplantation and therapy with fibrates on serum cholesterol levels in renal transplant patients.
    Fuhrer JA; Montandon A; Descoeudres C; Jaeger P; Horber FF
    Clin Nephrol; 1993 May; 39(5):265-71. PubMed ID: 8513604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.